Plan National De Prévention Et De Lutte Pandémie Grippale

Pandemic Preparedness and Response National Control Plan 2011
France French PDF
National

AI-Generated Document Summary

Objectives

The national influenza-pandemic plan provides a flexible, intersectoral framework for preparedness, response and recovery. Its overarching aims are to reduce deaths and illness in metropolitan France, overseas territories and among French nationals abroad; protect health services; preserve social and economic activity; and restore the closest possible return to normal conditions while preparing for further epidemic waves.

  • Prepare for uncertain pandemics whose health and societal effects may vary with viral transmissibility and severity, population vulnerability, pre-existing immunity, concurrent infections and the capacity of health and care services.
  • Structure action around an initial alert and four stages: limit introduction, limit territorial spread, mitigate the epidemic wave, and return to the prior situation while anticipating a possible subsequent wave.
  • Identify the virus, slow transmission at source, protect the public and exposed professionals, organise care, develop and deploy vaccines, and reduce health impacts through proportionate public-health and healthcare measures.
  • Maintain continuity of government, essential services, economic activity, public order and household support, while protecting vulnerable people and sustaining social cohesion.
  • Apply ethical principles of solidarity, non-stigmatisation and transparent priority-setting for vaccines and other health products, including equal protection for foreign residents in France and support for French citizens abroad.
  • Use vaccination to reduce transmission, severe disease and deaths, prioritising people at greatest medical risk, groups contributing substantially to transmission, particularly children, and essential personnel.

Implementation

The plan combines nationally defined strategic measures with adaptable operational guidance for territorial implementation, health-system delivery, vaccination, distribution of health products, communication and activity continuity. Measures are escalated or reoriented according to the evolving threat, available resources, care-system pressures and societal consequences, recognising that no plan can anticipate every scenario.

  • Coordinate national preparation through the General Secretariat for Defence and National Security, the Interministerial Delegate for Avian Influenza, the ministries responsible for health and the interior, the Government Information Service and all ministerial departments.
  • Use the prefectural territorial chain for crisis management: defence and security zone prefects coordinate departmental planning and crisis measures, regional health agencies support care organisation and surveillance, and departmental prefects may activate expanded hospital emergency arrangements, intermediate accommodation and health-reserve deployment.
  • Prepare national, zonal and departmental arrangements; update animal-influenza plans; conduct exercises; clarify responsibilities; reinforce personnel; and secure resources, logistics and health-product supplies before a crisis.
  • Strengthen surveillance, epidemiological anticipation, laboratory diagnosis, hospital and community care, emergency medical services, and tailored arrangements for children, pregnant women, disabled people, older people and disadvantaged populations.
  • Maintain reserves and distribution capacity for antivirals, antibiotics, vaccines, masks, medical devices and protective equipment, while preparing exceptional vaccination arrangements, including prioritisation, professional training, public mobilisation and procurement from multiple manufacturers where appropriate.
  • Apply containment while transmission remains geographically limited through case finding, early management, contact investigation, traveller surveillance and measures to delay domestic outbreaks.
  • Shift progressively to mitigation when community transmission persists, contact-tracing capacity is exceeded or intensive care, paediatric, primary-care or emergency-service capacity risks saturation; then focus resources on care for symptomatic people, vulnerable-group protection, barrier measures and reducing health-system pressure.
  • Use routine care pathways where possible, with community doctors managing patients not requiring intensive care and healthcare establishments treating hospital cases regulated by the SAMU-Centre 15 emergency medical service.
  • Require administrations, local authorities, businesses and operators of vital importance to maintain continuity plans covering priority missions, essential staff, personnel protection, degraded-mode operation, redeployment, remote working and teleconferencing.
  • Engage mayors, local authorities, voluntary organisations, families, neighbours, employers, health professionals and citizens in hygiene, local assistance, support for isolated people, childcare, continuity of essential services and responsible adherence to measures.
  • Coordinate with European Union Member States, the European Commission, the World Health Organization and other international bodies on surveillance, notification, transport measures, health-product issues, research and risk communication.
  • Protect French citizens abroad through locally adapted diplomatic-post plans, medical-adviser networks, pre-positioned health products and masks, local care where feasible, possible reinforcement missions, and case-by-case medical evacuation or repatriation decisions.
  • Attach communication to every response measure, use health professionals, elected representatives, associations, online platforms and social networks as channels, monitor public opinion and rumours, explain decisions transparently and adapt information to particular population groups.
  • Monitor health and societal impact through epidemiological and virological surveillance, laboratory confirmation, pharmacovigilance, mortality data, care-capacity information, public-opinion intelligence and continuity indicators such as absenteeism and essential-service activity.
  • Evaluate the pandemic wave after the epidemic threshold declines, assess excess mortality and socio-economic effects, collect lessons from public and private actors, revise plans, replenish resources and continue vaccination where needed for possible later waves.

Monitoring & Evaluation

The plan establishes a comprehensive monitoring and decision-support approach for pandemic preparedness, response and recovery. It combines epidemiological, virological, clinical, pharmacovigilance, health-system, socio-economic and public-opinion intelligence to support proportionate adaptation of measures across the initial alert and four epidemic stages.

  • Monitor pandemic impact through mortality, morbidity and disruption caused by saturation of health and care services, interpreting these outcomes in light of viral transmissibility and virulence, population vulnerability, immunity, climatic conditions, concurrent viruses and care capacity.
  • Maintain enhanced epidemiological surveillance and anticipation capacity, including case detection, laboratory diagnosis, investigation of cases and contacts, traveller surveillance, international intelligence and territorial epidemiological syntheses.
  • Coordinate influenza surveillance through the French Institute for Public Health Surveillance, regional influenza observation groups, the Sentinelles network, the Oscour hospital network, death-certificate-based mortality estimation, and national reference centres for virological surveillance.
  • Supplement routine surveillance during a pandemic by monitoring severe intensive-care cases, influenza deaths in real time, human and animal influenza internationally, circulating viral strains and antiviral resistance.
  • Track active community transmission, the capacity to investigate cases and contacts, and risks of saturation in intensive care, paediatrics, primary care and emergency medical services as triggers for transition from containment to attenuation.
  • Monitor care capacity, including outpatient provision, through regional health agencies, and consolidate departmental information through the prefectural chain for the health ministry’s crisis centre and interministerial crisis-management arrangements.
  • Use preparedness indicators and cross-ministerial and local-authority data-collection pathways, alongside ministerial situation indicators, to support crisis assessment and national coordination.
  • Assess socio-economic continuity through zonal observatories, information exchange and activity indicators covering energy, electronic communications, transport, payments, food and water supply, and workplace absenteeism.
  • Monitor economic conditions and pandemic-related costs, product prices and availability, essential-service supply arrangements, affected households and businesses, insurance-compensation processes, and activities requiring priority recovery.
  • Monitor media, online information, social networks, public opinion, risk perception, concerns, adherence to measures and rumours, then use communication channels to correct misinformation and explain decisions.
  • Assess vaccine strategy continuously in relation to epidemiological evolution, severity, expected health, social and economic effects, target groups, coverage, supply packaging and public and professional acceptance.
  • Conduct pharmacovigilance through reporting, data collection, evaluation and safety studies, involving patients, health professionals, regional centres, the French health-products safety agency and pharmaceutical companies.
  • Test preparedness through exercises, including at least one annual plan-implementation exercise organised by each zone prefecture and wider exercises involving defence, interior, health and other public and private actors.
  • Evaluate the pandemic wave after the epidemic threshold declines, estimate final excess mortality from death-certificate statistics, document lessons from partners, and revise national, ministerial, public and private plans in preparation for possible subsequent waves.

Historical experience informs assessment but is not presented as a fixed performance threshold: reference estimates include about 200,000 deaths in France in 1918 to 1920, about 30,000 in each of 1957 to 1958 and 1968 to 1970, and approximately 350 officially counted deaths, with a potentially more complete estimate of around 1,000, in 2009.The framework also draws operational lessons from 2009, when case reporting, isolation, antiviral treatment and school closures appeared to delay spread in France.

Reporting and accountability are primarily embedded in surveillance, prefectural information flows, crisis coordination, European notification channels and ongoing ministerial monitoring.The supplied material does not define a single consolidated indicator set, quantified performance targets, uniform reporting timetable, independent audit process or separate formal accountability framework.

Costing & Financing

The plan identifies substantial resource needs across preparedness, response and recovery, but the supplied material provides almost no quantified national financing information. The sole explicit monetary estimate is a World Bank estimate that a pandemic with the contemporary severity of the Spanish flu would cost 2,000 billion euros, with absenteeism identified as a major contributor to economic losses.

  • Maintain and replenish reserves of health products, medical equipment and protective materials, including antivirals, antibiotics, vaccines, masks and extracorporeal membrane oxygenation equipment.
  • Acquire, secure, store and distribute health products, personal protective equipment, vaccines and injection devices, while protecting production and storage facilities and preparing logistics for deployment.
  • Strengthen laboratory, surveillance, hospital, ambulatory-care, emergency-service, staffing and transport capacity to manage sustained patient demand and possible care-system saturation.
  • Prepare exceptional vaccination arrangements, including prioritisation, vaccine reservation or procurement, professional training, public mobilisation and delivery through routine or dedicated vaccination facilities.
  • Reduce vaccine-procurement risk by spreading pandemic-vaccine orders across several manufacturers because delivery dates may be uncertain.
  • Support continuity measures for government, local authorities, businesses and essential sectors, including remote working, teleconferencing, personnel protection, degraded-mode operations and reinforcement of priority functions.
  • Provide support for affected households, businesses and sectors, including insurance compensation, partial-unemployment arrangements and economic or financial measures where needed.
  • Maintain health-product and mask stocks at diplomatic posts abroad and allow for locally approved human or material reinforcements, medical missions and other consular or medical support subject to available resources.

The plan calls for monitoring socio-economic conditions and the economic costs of a pandemic, including disruption from absenteeism and continuity risks.However, the supplied extracts do not specify a national implementation budget, funding envelope, unit costs, financing sources, allocation formula, funding gap, resource-mobilisation target or detailed economic assumptions beyond the World Bank estimate.

Document Viewer